<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97549">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02039557</url>
  </required_header>
  <id_info>
    <org_study_id>GC P# 04.01.020/030</org_study_id>
    <nct_id>NCT02039557</nct_id>
  </id_info>
  <brief_title>Long Term Follow Up Protocol for NiCord Patients</brief_title>
  <official_title>Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gamida Cell ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gamida Cell ltd</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study that will monitor patient's clinical outcomes.  A patient can
      enroll in the NiCord® Long Term Follow Up Protocol only after the informed consent has been
      signed, and he/she has completed the study specific follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>long term sustained engraftment of NiCord® transplantation</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Patients Transplanted With NiCord®</condition>
  <arm_group>
    <arm_group_label>NiCord transplanted</arm_group_label>
    <description>Anyone who has received a NiCord® transplant, completed study specific follow up, and has signed the consent for this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>NiCord</intervention_name>
    <arm_group_label>NiCord transplanted</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        NiCord transplanted patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Anyone who has received a NiCord® transplant, completed study specific follow up, and
             has signed the consent for this study.

        Exclusion Criteria

          -  None
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitch Horwitz, MD</last_name>
      <phone>919-668-1045</phone>
      <email>mitchell.horwitz@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Mitch Horwitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 19, 2014</lastchanged_date>
  <firstreceived_date>January 13, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
